BioCentury | Jun 20, 2020
Translation in Brief

CAR Ts against senescent cells; plus NIH program for ALS, sex-dependent COVID-19 immune responses and more

...cytokines, smaller atherosclerotic lesions and improved gut barrier integrity. Neutralizing mAbs from COVID-19 recovered patients University of Amsterdam...
...Tumor necrosis factor (TNF)-related apoptosis-inducing ligand BioCentury Staff Memorial Sloan Kettering Cancer Center Scripps Research National Institutes of Health University of Amsterdam BridgeBio...
BioCentury | Oct 12, 2018
Finance

Spinning out Sitryx

...option to buy Sitryx or any of its compounds. Tak is a professor at the University of Amsterdam...
BioCentury | Nov 30, 2017
Strategy

Doctors in the house

...piece was actually bringing in senior academics into GSK,” said Tak, who remains affiliated with University of Amsterdam...
...Pink:MPSYY), Martinsried, Germany National Institutes of Health (NIH), Bethesda, Md. Trinity College Dublin, Dublin, Ireland University of Amsterdam...
BioCentury | Jan 18, 2017
Distillery Therapeutics

Infectious disease

...G. et al. Cell Rep. ; published online Dec. 13, 2016 doi:10.1016/j.celrep.2016.11.057 CONTACT: Ben Berkhout, University of Amsterdam...
...Amsterdam, the Netherlands email: b.berkhout@amc.uva.nl CONTACT: Atze T. Das, same affiliation as above email: a.t.das@amc.uva.nl Hongjiang Li University of Amsterdam CRISPR-associated...
BioCentury | Sep 15, 2016
Distillery Techniques

Techniques: Clonal diversity-based biomarker for disease progression in non-dysplastic Barrett's esophagus patients

...Trevor Graham, Queen Mary University of London , London, U.K. email: t.graham@qmul.ac.uk CONTACT: Kausilia Krishnadath, University of Amsterdam...
BioCentury | Jul 23, 2015
Distillery Techniques

Techniques: Activating mutations in the Ras-MAP kinase (MAPK) pathway to predict relapsed neuroblastoma response to MEK inhibitors

...MAP2K2 MEK2 Exelixis Inc. Genentech Inc. Roche Array BioPharma Inc. Institut Curie Academic Medical Center University of Amsterdam BC...
BioCentury | Feb 27, 2014
Distillery Therapeutics

Indication: Endocrine/metabolic disease

...al. Proc. Natl. Acad. Sci. USA; published online Feb. 3, 2014; doi:10.1073/pnas.1400419111 Contact: Esther Lutgens, University of Amsterdam...
BioCentury | May 20, 2013
Finance

Striking similarity

...of medicine in the department of vascular medicine at the Academic Medical Center of the University of Amsterdam...
BioCentury | May 13, 2013
Company News

Batavia Bioservices, University of Amsterdam deal

...May 2008. The partners did not disclose details. Batavia Bioservices B.V. , Leiden, the Netherlands University of Amsterdam...
BioCentury | Apr 15, 2013
Company News

Immunexpress, Center for Translational Molecular Medicine infectious news

...coming from the Dutch government. The consortium is enrolling more than 7,000 patients at the University of Amsterdam...
Items per page:
1 - 10 of 37
BioCentury | Jun 20, 2020
Translation in Brief

CAR Ts against senescent cells; plus NIH program for ALS, sex-dependent COVID-19 immune responses and more

...cytokines, smaller atherosclerotic lesions and improved gut barrier integrity. Neutralizing mAbs from COVID-19 recovered patients University of Amsterdam...
...Tumor necrosis factor (TNF)-related apoptosis-inducing ligand BioCentury Staff Memorial Sloan Kettering Cancer Center Scripps Research National Institutes of Health University of Amsterdam BridgeBio...
BioCentury | Oct 12, 2018
Finance

Spinning out Sitryx

...option to buy Sitryx or any of its compounds. Tak is a professor at the University of Amsterdam...
BioCentury | Nov 30, 2017
Strategy

Doctors in the house

...piece was actually bringing in senior academics into GSK,” said Tak, who remains affiliated with University of Amsterdam...
...Pink:MPSYY), Martinsried, Germany National Institutes of Health (NIH), Bethesda, Md. Trinity College Dublin, Dublin, Ireland University of Amsterdam...
BioCentury | Jan 18, 2017
Distillery Therapeutics

Infectious disease

...G. et al. Cell Rep. ; published online Dec. 13, 2016 doi:10.1016/j.celrep.2016.11.057 CONTACT: Ben Berkhout, University of Amsterdam...
...Amsterdam, the Netherlands email: b.berkhout@amc.uva.nl CONTACT: Atze T. Das, same affiliation as above email: a.t.das@amc.uva.nl Hongjiang Li University of Amsterdam CRISPR-associated...
BioCentury | Sep 15, 2016
Distillery Techniques

Techniques: Clonal diversity-based biomarker for disease progression in non-dysplastic Barrett's esophagus patients

...Trevor Graham, Queen Mary University of London , London, U.K. email: t.graham@qmul.ac.uk CONTACT: Kausilia Krishnadath, University of Amsterdam...
BioCentury | Jul 23, 2015
Distillery Techniques

Techniques: Activating mutations in the Ras-MAP kinase (MAPK) pathway to predict relapsed neuroblastoma response to MEK inhibitors

...MAP2K2 MEK2 Exelixis Inc. Genentech Inc. Roche Array BioPharma Inc. Institut Curie Academic Medical Center University of Amsterdam BC...
BioCentury | Feb 27, 2014
Distillery Therapeutics

Indication: Endocrine/metabolic disease

...al. Proc. Natl. Acad. Sci. USA; published online Feb. 3, 2014; doi:10.1073/pnas.1400419111 Contact: Esther Lutgens, University of Amsterdam...
BioCentury | May 20, 2013
Finance

Striking similarity

...of medicine in the department of vascular medicine at the Academic Medical Center of the University of Amsterdam...
BioCentury | May 13, 2013
Company News

Batavia Bioservices, University of Amsterdam deal

...May 2008. The partners did not disclose details. Batavia Bioservices B.V. , Leiden, the Netherlands University of Amsterdam...
BioCentury | Apr 15, 2013
Company News

Immunexpress, Center for Translational Molecular Medicine infectious news

...coming from the Dutch government. The consortium is enrolling more than 7,000 patients at the University of Amsterdam...
Items per page:
1 - 10 of 37